Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

UnitedHealth Group Inc., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net earnings 5,675 6,038 5,657 5,774 4,908 5,384 5,199 5,148 4,191 4,191 4,372 4,978 2,352 3,256 6,696 3,465 3,668 3,629 3,385 3,557
Depreciation and amortization 974 1,007 1,021 970 982 828 802 788 771 796 778 758 732 719 717 723 718 709 654 639
Deferred income taxes 249 (12) (150) (332) (83) (575) (176) 161 (243) 46 (14) 341 (127) 5 (88) 202 53 (18) 61 134
Share-based compensation 208 247 242 362 250 171 205 299 209 165 170 256 152 139 157 231 172 127 155 243
Other, net (446) 32 (160) 69 (331) (215) 198 17 (749) 19 (159) (55) (100) (76) 79 45 75 (54) (169) 42
Noncash items 985 1,274 953 1,069 818 209 1,029 1,265 (12) 1,026 775 1,300 657 787 865 1,201 1,018 764 701 1,058
Accounts receivable (540) (2,771) 4,503 (4,306) 40 1,641 317 (4,521) (153) 371 1,677 (2,895) (494) 245 2,213 (2,652) (795) (1,239) 3,617 (1,421)
Other assets (86) (357) (126) (1,875) (633) (98) 446 (1,089) 404 88 (568) (955) 502 1,087 465 (4,249) 618 (407) (279) (1,495)
Medical costs payable (355) 1,429 (59) 2,467 (139) 163 180 3,849 (1,224) 839 118 2,968 767 1,738 (3,473) 1,120 998 (224) (678) 1,125
Accounts payable and other liabilities 1,146 823 (249) 1,796 548 609 218 589 (9) 873 (572) 870 1,907 (4,150) 3,454 4,137 628 138 (351) 318
Unearned revenues (12,018) 466 353 11,402 (10,075) 10,641 (518) 78 21 192 (262) (261) 410 164 (217) (79) 70 489 (521) 92
Net change in other operating items, net of effects from acquisitions and changes in AARP balances (11,853) (410) 4,422 9,484 (10,259) 12,956 643 (1,094) (961) 2,363 393 (273) 3,092 (916) 2,442 (1,723) 1,519 (1,243) 1,788 (1,381)
Cash flows from operating activities (5,193) 6,902 11,032 16,327 (4,533) 18,549 6,871 5,319 3,218 7,580 5,540 6,005 6,101 3,127 10,003 2,943 6,205 3,150 5,874 3,234
Purchases of investments (5,316) (3,773) (4,331) (4,894) (4,642) (5,280) (3,921) (4,982) (4,312) (3,980) (4,235) (4,612) (5,007) (5,158) (2,546) (3,866) (4,745) (5,737) (4,109) (3,540)
Sales of investments 3,633 486 2,732 456 531 3,028 757 1,591 4,476 1,161 765 643 1,602 1,339 1,378 2,170 2,338 3,518 1,170 1,510
Maturities of investments 2,756 2,011 2,344 2,119 1,341 1,551 1,430 1,759 1,695 1,906 2,395 2,255 1,955 1,860 1,711 1,726 1,931 1,845 1,604 1,711
Cash paid for acquisitions, net of cash assumed (1,747) (228) (335) (7,826) (14,304) (4) (5,919) (1,231) (94) (85) (3,449) (1,193) (2,813) (374) (3,023) (929) (143) (3,449) (4,062) (689)
Purchases of property, equipment and capitalized software (959) (838) (829) (760) (866) (724) (657) (555) (695) (629) (562) (568) (574) (557) (451) (469) (650) (444) (415) (562)
Cash received from dispositions 685 3,414
Other, net (239) (297) (309) (115) (843) 582 (277) (255) (354) (252) (416) (232) (341) 21 (21) (165) (119) (166) 350 154
Cash flows used for investing activities (1,187) (2,639) (728) (11,020) (15,369) (847) (8,587) (3,673) 716 (1,879) (5,502) (3,707) (5,178) (2,869) (2,952) (1,533) (1,388) (4,433) (5,462) (1,416)
Common share repurchases (1,500) (1,500) (3,000) (2,000) (1,000) (1,000) (2,500) (2,500) (1,050) (1,050) (1,250) (1,650) (1,709) (850) (1,691) (399) (600) (1,499) (3,002)
Cash dividends paid (1,738) (1,739) (1,747) (1,537) (1,541) (1,542) (1,545) (1,363) (1,365) (1,367) (1,367) (1,181) (1,184) (1,188) (1,188) (1,024) (1,024) (1,024) (1,024) (860)
Proceeds from common stock issuances 314 411 284 344 169 328 205 551 278 313 328 436 234 336 313 557 297 292 125 323
Repayments of long-term debt (750) (1,375) (915) (1,000) (1,100) (1,250) (750) (1,150) (1,650) (1,500) (500) (1,250)
Proceeds from (repayments of) short-term borrowings, net (1,568) (1,847) (3,923) 7,349 748 (1,356) (1,808) 3,148 (1) (1,125) (4,233) 4,057 1,295 (774) (10,446) 10,797 (3,698) (2,926) 3,823 3,101
Proceeds from issuance of long-term debt (7) 6,401 8,897 5,922 (1) 6,934 4,864 5,444
Customer funds administered (2,558) (2,032) (943) 5,012 (1,480) 1,242 666 5,120 (780) (993) 264 2,131 1,428 (1,014) 201 1,062 (407) (1,015) (349) 1,784
Purchases of redeemable noncontrolling interests (730) (79) (97) (1,338)
Other, net 624 (397) (373) (1,004) (486) (9) 103 (1,552) 542 (175) 1,194 (1,856) (10) (28) (23) (398) (481) (227) (161) (368)
Cash flows from (used for) financing activities (7,156) (7,104) (10,459) 13,190 4,392 (3,416) 946 2,304 (3,627) (4,397) (218) 787 (1,596) (5,018) (6,279) 9,303 (6,212) (56) 915 (272)
Effect of exchange rate changes on cash and cash equivalents 48 (57) 55 51 30 (53) (100) 157 (17) (51) 57 (51) 44 (17) (14) (129) 17 (43) 11 (5)
Increase (decrease) in cash and cash equivalents (13,488) (2,898) (100) 18,548 (15,480) 14,233 (870) 4,107 290 1,253 (123) 3,034 (629) (4,777) 758 10,584 (1,378) (1,382) 1,338 1,541

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Cash flow statement item Description The company
Cash flows from operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. UnitedHealth Group Inc. cash flows from operating activities decreased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Cash flows used for investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. UnitedHealth Group Inc. cash flows used for investing activities decreased from Q2 2023 to Q3 2023 but then increased from Q3 2023 to Q4 2023 not reaching Q2 2023 level.
Cash flows from (used for) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. UnitedHealth Group Inc. cash flows from (used for) financing activities increased from Q2 2023 to Q3 2023 but then slightly decreased from Q3 2023 to Q4 2023.